These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34496010)

  • 1. Activation status dictates the function of unlicensed natural killer cells in mice and humans.
    Aguilar EG; Dunai C; Judge SJ; Zamora AE; Khuat LT; Vick LV; Collins CP; Stoffel KM; Alvarez M; Barao I; Miller JS; Blazar BR; Chevallier P; Retiere C; Canter RJ; Murphy WJ
    Blood Adv; 2021 Oct; 5(20):4219-4232. PubMed ID: 34496010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.
    Sungur CM; Tang-Feldman YJ; Ames E; Alvarez M; Chen M; Longo DL; Pomeroy C; Murphy WJ
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7401-6. PubMed ID: 23589894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses.
    Sungur CM; Tang-Feldman YJ; Zamora AE; Alvarez M; Pomeroy C; Murphy WJ
    Blood; 2013 Aug; 122(8):1518-21. PubMed ID: 23818546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection.
    Orr MT; Murphy WJ; Lanier LL
    Nat Immunol; 2010 Apr; 11(4):321-7. PubMed ID: 20190757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell licensing during viral infection.
    Orr MT; Lanier LL
    Adv Exp Med Biol; 2011; 780():37-44. PubMed ID: 21842363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licensing delineates helper and effector NK cell subsets during viral infection.
    Zamora AE; Aguilar EG; Sungur CM; Khuat LT; Dunai C; Lochhead GR; Du J; Pomeroy C; Blazar BR; Longo DL; Venstrom JM; Baumgarth N; Murphy WJ
    JCI Insight; 2017 May; 2(10):. PubMed ID: 28515356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell licensing in mice with inducible expression of MHC class I.
    Ebihara T; Jonsson AH; Yokoyama WM
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):E4232-7. PubMed ID: 24145414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.
    Forbes CA; Scalzo AA; Degli-Esposti MA; Coudert JD
    J Immunol; 2016 Jul; 197(1):128-40. PubMed ID: 27233959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-Mediated Activation of NK Cells during Viral Infection.
    Freeman BE; Raué HP; Hill AB; Slifka MK
    J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of Dk-licensed Ly49G2+ NK cells in viral control.
    Prince J; Lundgren A; Stadnisky MD; Nash WT; Beeber A; Turner SD; Brown MG
    J Immunol; 2013 Nov; 191(9):4709-19. PubMed ID: 24068668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells.
    Lindenberg M; Solmaz G; Puttur F; Sparwasser T
    Virol J; 2014 Aug; 11():145. PubMed ID: 25108672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.
    Barao I; Alvarez M; Ames E; Orr MT; Stefanski HE; Blazar BR; Lanier LL; Anderson SK; Redelman D; Murphy WJ
    Blood; 2011 Jun; 117(26):7032-41. PubMed ID: 21498673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Viral Infection by Natural Killer Cell Inhibitory Receptors.
    Parikh BA; Bern MD; Piersma SJ; Yang L; Beckman DL; Poursine-Laurent J; Plougastel-Douglas B; Yokoyama WM
    Cell Rep; 2020 Jul; 32(4):107969. PubMed ID: 32726632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection.
    Nabekura T; Lanier LL
    Immunity; 2016 Jul; 45(1):74-82. PubMed ID: 27438766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control.
    Tu MM; Mahmoud AB; Makrigiannis AP
    Front Immunol; 2016; 7():166. PubMed ID: 27199990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses.
    Wagner JA; Berrien-Elliott MM; Rosario M; Leong JW; Jewell BA; Schappe T; Abdel-Latif S; Fehniger TA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):398-404. PubMed ID: 27894857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
    Yu J; Venstrom JM; Liu XR; Pring J; Hasan RS; O'Reilly RJ; Hsu KC
    Blood; 2009 Apr; 113(16):3875-84. PubMed ID: 19179302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
    Rogatko-Koroś M; Mika-Witkowska R; Bogunia-Kubik K; Wysoczańska B; Jaskuła E; Kościńska K; Nestorowicz K; Dziopa J; Szlendak U; Gwozdowicz S; Graczyk-Pol E; Lange A; Nowak J
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):63-71. PubMed ID: 27933342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.